Peter E. Czabotar
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Towards a molecular and structural definition of cell death.
Journal: Nature structural & molecular biology
Published: September 18, 2025
Computational design of potent and selective binders of BAK and BAX.
Journal: Science advances
Published: September 05, 2025
Differential regulation of BAX and BAK apoptotic activity revealed by small molecules.
Journal: Science advances
Published: March 05, 2025
The BCL-2 protein family: from discovery to drug development.
Journal: Cell death and differentiation
Published: January 31, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.
Journal: Nature communications
Published: December 18, 2024
Structure-activity analysis of imino-pyrimidinone-fused pyrrolidines aids the development of dual plasmepsin V and plasmepsin X inhibitors.
Journal: The FEBS journal
Published: August 16, 2024
Structure, function, surf, repeat: A week at Lorne Proteins 2024.
Journal: Structure (London, England : 1993)
Published: August 08, 2024
Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia.
Journal: Blood advances
Published: August 05, 2024
Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis.
Journal: Current opinion in structural biology
Published: April 30, 2024
Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis.
Journal: PLoS biology
Published: December 23, 2023
A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells.
Journal: Cell death and differentiation
Published: November 13, 2023
Last Updated: 09/26/2026